MX2017000829A - Composiciones de azucares para la formacion de comprimidos mediante compresion directa. - Google Patents

Composiciones de azucares para la formacion de comprimidos mediante compresion directa.

Info

Publication number
MX2017000829A
MX2017000829A MX2017000829A MX2017000829A MX2017000829A MX 2017000829 A MX2017000829 A MX 2017000829A MX 2017000829 A MX2017000829 A MX 2017000829A MX 2017000829 A MX2017000829 A MX 2017000829A MX 2017000829 A MX2017000829 A MX 2017000829A
Authority
MX
Mexico
Prior art keywords
tableting
direct compression
sugar compositions
compositions
sugar
Prior art date
Application number
MX2017000829A
Other languages
English (en)
Inventor
Lanos Pierre
Boit Baptiste
Buquet Fabrice
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of MX2017000829A publication Critical patent/MX2017000829A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a composiciones directamente compresibles que comprenden más de 30% en peso de alulosa, y a comprimidos obtenibles a partir de las mismas.
MX2017000829A 2014-07-21 2015-07-16 Composiciones de azucares para la formacion de comprimidos mediante compresion directa. MX2017000829A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306181 2014-07-21
PCT/IB2015/001302 WO2016012853A1 (en) 2014-07-21 2015-07-16 Sugar compositions for tableting by direct compression

Publications (1)

Publication Number Publication Date
MX2017000829A true MX2017000829A (es) 2017-05-01

Family

ID=51265637

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000829A MX2017000829A (es) 2014-07-21 2015-07-16 Composiciones de azucares para la formacion de comprimidos mediante compresion directa.

Country Status (11)

Country Link
US (3) US20170208849A1 (es)
EP (1) EP3171709A1 (es)
JP (1) JP6731400B2 (es)
KR (1) KR102557664B1 (es)
CN (1) CN106659225B (es)
BR (1) BR112017001000B1 (es)
CA (1) CA2955845C (es)
CL (1) CL2017000153A1 (es)
MX (1) MX2017000829A (es)
SG (1) SG11201700445YA (es)
WO (1) WO2016012853A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105148280A (zh) * 2015-07-07 2015-12-16 深圳国源国药有限公司 一种创新药用辅料可压性蔗糖及其制备方法
FR3061413B1 (fr) 2017-01-05 2021-08-27 Roquette Freres Procede de fabrication de cristaux de d-allulose
US10925853B2 (en) * 2019-04-17 2021-02-23 Nordiccan A/S Oral cannabinoid tablet
EP4142518A1 (en) * 2020-04-30 2023-03-08 Firmenich SA Flavor particle, its process of manufacture and use for stabilizing flavor
EP4000419A1 (de) * 2020-11-23 2022-05-25 Savanna Ingredients GmbH Trocknung von allulosekristallen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3305447A (en) 1963-06-12 1967-02-21 American Sugar Tabletting sugar and method of preparing same
US3627583A (en) 1969-04-29 1971-12-14 Sucrest Corp Direct compression vehicles
US4698101A (en) * 1982-08-30 1987-10-06 Suomen Sokeri Oy (Finnish Sugar Company Ltd.) Binder-diluent composition and method
FI104787B (fi) * 1989-06-07 2000-04-14 Xyrofin Oy Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi
DE60036205T2 (de) 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
KR100908626B1 (ko) * 2002-05-22 2009-07-21 고쿠리츠다이가쿠호우징 카가와다이가쿠 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
JP4761424B2 (ja) * 2004-03-17 2011-08-31 株式会社希少糖生産技術研究所 Ｌ−プシコース結晶、その製造方法および、糖試薬キット
EP1757297B1 (en) 2004-05-26 2013-11-13 National University Corporation Kagawa University COMPOSITION FOR treating ARTERIOSCLEROSIS IN DIABETIC PATIENTS
EP1864669B1 (en) * 2005-03-23 2018-06-27 Rare Sugar Production Technical Research Laboratories, LLC Application of d-psicose to suppression of abnormal circadian increase in blood glucose level
JP5116071B2 (ja) * 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
KR101325061B1 (ko) * 2006-11-10 2013-11-05 고쿠리츠다이가쿠호우징 카가와다이가쿠 Ｄ-사이코스 함유 감미료 및 그것을 사용하여 얻어진 식품
KR101373591B1 (ko) 2006-11-17 2014-03-12 마쓰다니가가꾸고오교가부시끼가이샤 글루코키나아제의 핵으로부터 세포질로의 이행의 촉진화제로서, 희소당의 기능의 이용
WO2008142860A1 (ja) 2007-05-18 2008-11-27 Matsutani Chemical Industry Co., Ltd. 砂糖様味質をもつ新規甘味料、その製造法および用途
FR2925499B1 (fr) * 2007-12-20 2010-02-12 Roquette Freres Maltitol granule pour compression directe et son procede de preparation
JP5859191B2 (ja) * 2010-09-29 2016-02-10 松谷化学工業株式会社 高甘味度甘味料に対する呈味改良組成物およびその応用
JP6216493B2 (ja) 2011-06-24 2017-10-18 国立大学法人 香川大学 寿命延長剤
CN102697744B (zh) * 2012-05-29 2013-11-27 安吉东来药用辅料有限责任公司 阿洛糖片剂赋形剂、药物片剂及药物片剂的制备方法
EP2992887B1 (en) * 2013-04-26 2021-03-03 Matsutani Chemical Industry Co., Ltd. Agent for accelerating the energy expenditure and/or for improving the diminished energy expenditure functionality

Also Published As

Publication number Publication date
WO2016012853A1 (en) 2016-01-28
BR112017001000A2 (pt) 2017-11-14
CL2017000153A1 (es) 2017-07-28
CN106659225B (zh) 2021-04-02
BR112017001000B1 (pt) 2021-11-30
US20220240560A1 (en) 2022-08-04
EP3171709A1 (en) 2017-05-31
SG11201700445YA (en) 2017-02-27
US20170208849A1 (en) 2017-07-27
CA2955845A1 (en) 2016-01-28
JP6731400B2 (ja) 2020-07-29
US11986002B2 (en) 2024-05-21
US11350658B2 (en) 2022-06-07
US20190090528A1 (en) 2019-03-28
KR102557664B1 (ko) 2023-07-20
JP2017522032A (ja) 2017-08-10
KR20170030524A (ko) 2017-03-17
CA2955845C (en) 2022-08-16
CN106659225A (zh) 2017-05-10

Similar Documents

Publication Publication Date Title
MX2017000827A (es) Composiciones de azucar para la formacion de comprimidos por compresion directa.
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
PH12016501966A1 (en) Compounds and compositions as toll-like receptor 7 agonists
PH12016501151A1 (en) Nrf2 regulators
MX2019011496A (es) Composiciones de niraparib.
MX2019015744A (es) Composiciones farmaceuticas.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
PH12017500836A1 (en) Transdermal formulations
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
MX2019009606A (es) Bis-compuestos para dispositivos opticamente activos.
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
MX2016013029A (es) Compuestos de indanona sustituidos como modulares de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados.
MX2017000829A (es) Composiciones de azucares para la formacion de comprimidos mediante compresion directa.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX2014005510A (es) Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas.
MX2017007377A (es) Compuestos organicos.
MX2018000515A (es) Compuestos fluorados de cbd, composiciones y usos de los mismos.
MX2018000743A (es) Granulos de manitol para compresion directa.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
IN2014CH00840A (es)
MX2018005134A (es) Formulacion de factor viii (fviii).
MX371158B (es) Compuestos inhibidores de pde2.